Baird Reiterates an 'Outperform' on Onyx Pharmaceuticals (ONXX); Raising Kyprolis Estimates
Tweet Send to a Friend
Baird reiterates an 'Outperform' on Onyx Pharmaceuticals (NASDAQ: ONXX) price target of $86.00 (from $80.00).
Analyst, Christopher J. Raymond ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Christopher J. Raymond ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE